-
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
-
2023-506537-29-00
5
2025-02-24
Haemophilia A
-
2024-518399-29-00
5
2024-12-27
Testicular cancer
-
2024-513077-48-00
5
2024-12-19
O6-methylguanine methyltransferase (MGMT) unmethylated glioblastoma
-
2024-514135-17-00
5
2024-11-28
Immunoglobulin A Nephropathy
-
2024-511404-17-00
5
2024-10-07
Unresectable or metastatic NRAS mutant cutaneous melanoma
-
2023-504231-41-01
10
2024-10-02
Locally advanced or metastatic urothelial cancer
-
2024-512268-77-00
6
2024-10-02
Cataract
-
2023-506091-27-00
4
2024-09-19
Achondroplasia in Children and Adolescents
-
2023-504918-29-00
5
2024-08-22
Hormone receptor positive breast cancer
-
2023-507129-40-00
4
2024-08-06
interstitial lung disease secondary to systemic sclerosis (SSc-ILD)
-
2023-504308-27-00
5
2024-06-06
non-squamous non-small cell lung cancer
-
2023-505962-28-00
5
2024-05-08
Persistent symptomatic atrial fibrillation
-
2023-505775-70-00
4
2024-04-08
High risk smoldering multiple myeloma
-
2023-504307-88-00
5
2024-02-20
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
-
2023-503920-14-00
5
2024-01-02
Non-Small Cell Lung Cancer (NSCLC)
-
2023-505000-27-01
4
2023-12-29
newly diagnosed pediatric FLT3-ITD positive and NPM1 wild-type AML
-
2022-501980-42-00
5
2023-12-21
Anemia associated with Chronic Kidney Disease
-
2022-503058-37-00
5
2023-11-10
Advanced Gastrointestinal Stromal Tumor
-
2022-503055-26-00
9
2023-10-30
Unresectable recurrent or metastatic HPV16 (Human Papilloma Virus) pos
-
2024-513995-16-00
10
2023-07-28
Neurogenic Detrusor Overactivity (NDO)
-
2022-500275-31-00
5
2023-06-20
Haemophilia A
-
2023-509810-13-00
4
2023-05-13
Acute Lymphoblastic Leukemia (ALL)
-
2022-501427-24-00
4
2023-04-25
Nonadvanced Systemic Mastocytosis